Edwin McElroy
Impact in
-
- Bone Tumor Diagnosis and Treatments
Papers in
-
- Amyloidosis: Diagnosis, Treatment, Outcomes 2
-
- Cancer-related cognitive impairment studies 2
- Co-authors
- Jan C. Buckner (1 shared paper)Jean E. Lewis (1 shared paper)Joseph Rubin (1 shared paper)Thomas E. Witzig (2 shared papers)Morie A. Gertz (2 shared papers)Robert A. Kyle (2 shared papers)Alex A. Adjei (1 shared paper)Jeff A. Sloan (1 shared paper)
- Journals
- The FASEB Journal (2 papers)British Journal of Haematology (1 paper)Blood (1 paper)Journal of Thoracic Oncology (1 paper)Liver Research (1 paper)
- Partner nations
- United StatesIndiaSaudi Arabia
In The Last Decade
Edwin McElroy
11 papers receiving 356 citations
Peers
Comparison fields: 5 of 51
- Otorhinolaryngology 18
- Rheumatology 52
- Hematology 38
- Surgery 144
- Oncology 89
Countries citing papers authored by Edwin McElroy
This map shows the geographic impact of Edwin McElroy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edwin McElroy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edwin McElroy more than expected).
Fields of papers citing papers by Edwin McElroy
This network shows the impact of papers produced by Edwin McElroy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edwin McElroy. The network helps show where Edwin McElroy may publish in the future.
Co-authors
The 25 scholars most cited alongside Edwin McElroy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 144 | |
| 2 | Phase I trial of dolastatin-10 (NSC 376128) in patients with advanced solid tumors. | 1999 | 94 |
| 3 | 2003 | 54 | |
| 4 | 2011 | 30 | |
| 5 | 1998 | 16 | |
| 6 | 1998 | 15 | |
| 7 | 2021 | 11 | |
| 8 | 2021 | 4 | |
| 9 | 2020 | 4 | |
| 10 | 2020 | 2 | |
| 11 | 2020 | 1 |
About Edwin McElroy
Edwin McElroy is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Surgery, Genetics and Epidemiology, having authored 11 papers that have together received 375 indexed citations. Recurring topics across this work include Cancer-related cognitive impairment studies (2 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (2 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (1 paper), Alzheimer's disease research and treatments (1 paper), Neuroendocrine Tumor Research Advances (1 paper), Renal Diseases and Glomerulopathies (1 paper), Liver Disease Diagnosis and Treatment (1 paper) and Mast cells and histamine (1 paper). The work is most often cited by research in Otorhinolaryngology (18 citations), Rheumatology (52 citations), Hematology (38 citations), Surgery (144 citations) and Oncology (89 citations). Edwin McElroy has collaborated with scholars based in United States, India and Saudi Arabia. Frequent co-authors include Jan C. Buckner, Jean E. Lewis, Joseph Rubin, Thomas E. Witzig, Morie A. Gertz, Robert A. Kyle, Alex A. Adjei, Jeff A. Sloan, Henry C. Pitot and R. M. Goldberg. Their work appears in journals such as The FASEB Journal, British Journal of Haematology, Blood, Journal of Thoracic Oncology and Liver Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.